Evidence map›Paper›PMID 35532585›Full record

ReviewThe Indian journal of medical research2021

Concurrent dengue infections: Epidemiology & clinical implications.

P D N N Sirisena, Shakuntala Mahilkar, Chetan Sharma, Jaspreet Jain, Sujatha Sunil

Open access · diamondAbstract readReview
In one paragraph

Review in The Indian journal of medical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Acute Rickettsiosis TriggeringPathogens (Basel, Switzerland) · 2025
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Recommendations for dengue vaccine implementation in the elderly population.Therapeutic advances in vaccines and immunotherapy · 2025
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

P D N N SirisenaImmunifyMe Healthcare Technologies Pvt. Ltd., Altrade Business Centre, Gurugram, Haryana, India.
Shakuntala MahilkarVector Borne Diseases Group, International Centre for Genetic Engineering & Biotechnology, New Delhi, India.
Chetan SharmaVector Borne Diseases Group, International Centre for Genetic Engineering & Biotechnology, New Delhi, India.
Jaspreet JainHuman Retrovirology Laboratory, Montreal Clinical Research Institute (IRCM), Montreal, Quebec H2W 1R7, Canada.
Sujatha SunilVector Borne Diseases Group, International Centre for Genetic Engineering & Biotechnology, New Delhi, India.
International Centre for Genetic Engineering and Biotechnology · INInternational Centre for Genetic Engineering and Biotechnology · ITMontreal Clinical Research Institute · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple dengue virus (DENV) serotypes circulating in a geographical area most often lead to simultaneous infection of two or more serotypes in a single individual. The occurrence of such concurrent infections ranges from 2.5 to 30 per cent, reaching as high as 40-50 per cent in certain dengue hyper-endemic areas. Concurrent dengue manifests itself differently than mono-infected patients, and it becomes even more important to understand the effects of co-infecting serotypes in concurrent infections to ascertain the clinical outcomes of the disease progression and transmission. In addition, there have also been reports of concurrent DENV infections in the presence of other arboviral infections. In this review, we provide a comprehensive breakdown of concurrent dengue infections globally. Furthermore, this review also touches upon the clinical presentations during those concurrent infections categorized as mild or severe forms of disease presentation. Another aspect of this review was aimed at providing insight into the concurrent dengue incidences in the presence of other arboviruses.

Indexed as

DengueDengue VirusDisease OutbreaksHumansIncidenceSerogroupConcurrent dengue infectionsdengue serotypesepidemiologypublic health

Identifiers

PMID35532585
PMCPMC9210535
OpenAlexW4285525993

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.